Bob is a great salesman is undisputed, however he did raise some interesting questions to consider as relevant.
He stated that that cancer is the number one reason for bankruptcy in the USA. How will doctors who are making money out of the bankrupt money react to making less money by detecting cancer sooner using IBX technology and treating it? How will they replace money lost?
What other technology will they need to learn to continue making the current money they make?
Second is he wants to open 50 clinical studies in the USA where studies cost more money so there will be more Cash Raisings.
How will they use Mercer for extra funding and why have they not put more money in now instead of waiting for later and how many years later is Bob really expecting as the Monash contract was for about 5 years. Any readers have better information?
Will the money spent in the USA affect the R&D refunds they will get out of the Australian government unless there are are changes by current government.
Another question is how have they been recieved by the Australian Cancer Council and have they been able to get funding for the clinical trials?
- Forums
- ASX - By Stock
- Where is IBX headed
Bob is a great salesman is undisputed, however he did raise some...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
IBX (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online